These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 4956387)
1. The effect of three butyrophenones on serum cholesterol levels. Simpson GM; Cooper TB Curr Ther Res Clin Exp; 1966 May; 8(5):249-55. PubMed ID: 4956387 [No Abstract] [Full Text] [Related]
2. The clinical position of moperone among the butyrophenones. Gross H; Kaltenbäck E Nord Psykiatr Tidsskr; 1969; 23(1):4-9. PubMed ID: 5354545 [No Abstract] [Full Text] [Related]
4. Further studies on the effect of butyrophenones on cholesterol synthesis in humans. Simpson GM; Cooper TB; Braun GA Curr Ther Res Clin Exp; 1967 Aug; 9(8):413-8. PubMed ID: 4962465 [No Abstract] [Full Text] [Related]
5. [Experience with the butyrophenone preparation Luvatren in the therapy of schizophrenia]. Weiser G Wien Med Wochenschr; 1968 May; 118(19):444-6. PubMed ID: 5702494 [No Abstract] [Full Text] [Related]
6. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia. Angus JW; Go SH; Simpson GM Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043 [No Abstract] [Full Text] [Related]
7. Psychotropic drugs used in the management of schizophrenia. Bueno JR; Himwich HE Int J Neurol; 1967; 6(1):77-93. PubMed ID: 5630202 [No Abstract] [Full Text] [Related]
9. A pilot study of AL-1021 in chronic schizophrenic patients. Sugerman AA Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042 [No Abstract] [Full Text] [Related]
10. [Clinical report on a high potency neuroleptic agent with certain specific 24-hour-effect after oral administration]. Zick WH Med Welt; 1969 Jul; 30():1659-61. PubMed ID: 5355657 [No Abstract] [Full Text] [Related]
12. A pilot study on the use of AL-1021 in the treatment of acute schizophrenics. Gendron JL; Schiele BC Curr Ther Res Clin Exp; 1971 Mar; 13(3):169-73. PubMed ID: 4998288 [No Abstract] [Full Text] [Related]
13. Cardiotoxic effects of a new butyrophenone compound. U-25,927. O'Meallie L; Gallant DM; Bishop MP; Bishop G; Steele CA Curr Ther Res Clin Exp; 1969 Jul; 11(7):460-70. PubMed ID: 4979995 [No Abstract] [Full Text] [Related]
14. [Chemistry and pharmacology of the butyrophenones]. Roos BE Nord Psykiatr Tidsskr; 1968; 22(3):229-34. PubMed ID: 5711257 [No Abstract] [Full Text] [Related]
15. A pilot study of AHR-1900 in chronc schizophrenic patients. Sugerman AA; Herrmann J; O'Hara M Curr Ther Res Clin Exp; 1970 Apr; 12(4):234-6. PubMed ID: 4989873 [No Abstract] [Full Text] [Related]
17. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study. Dursun SM; Szemis A; Andrews H; Reveley MA J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536 [TBL] [Abstract][Full Text] [Related]
18. [Results of apharmacological study of methoran--a preparation with neuroleptic activity]. Germane SK; Kimenis AA Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1390-4. PubMed ID: 5700613 [No Abstract] [Full Text] [Related]